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ABSTRACT
Background: Lactobacillus paracasei strain KW3110 has been shown by in vitro cytokine secretion analysis
to be a potent Th1 inducer and Th2 repressor. Oral administration of L. paracasei strain KW3110 also re-
presses IgE elevation in the ovalbumin sensitized mouse allergy model.
Methods: During pollen season from January to April in 2003, a daily dose of 4×1010 cfu L. paracasei strain
KW3110 was fed for 12 weeks as a yogurt to 14 pollen allergy patients(mean age 39.0 years). A yogurt made
with Lactobacillus delbrueckii strain B, shown to be a poor Th1 inducer and Th2 repressor in a former study,
was also fed at a daily dose of 4×1010 cfu for 12 weeks to 14 pollen allergy patients(mean age, 39.0 years).
Blood samples were collected every 4 weeks. Eosinophils, eosinophil cationic protein(ECP), non-specific se-
rum IgE, cedar pollen specific serum IgE, and Th1Th2 ratios were quantified．
Results: Twelve weeks after ingestion of the yogurts, the group that was fed L. delbrueckii group showed sig-
nificant reductions in the Th1Th2 ratios between the first observation in January and last observation in April,
representing the four month study period, due to increases in Th2 cells. Significant increases in ECP were also
observed in the group fed L. delbrueckii between January and April. In contrast, the group fed L. paracasei had
no significant changes in the ECP and Th1Th2 ratios.
Conclusions: Our results suggest that ingestion of the L. paracasei strain KW3110 is associated with both
repression of Th2 cell generation and eosinophil activation. Our data point to the possibility that specific lactic
acid bacteria may be useful for allergy therapy.
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INTRODUCTION
There is growing interest in the anti-allergic effect of
lactic acid bacteria(LAB). We have recently shown
that LAB strains vary widely in the ability to improve
the consequences of the Th1Th2 imbalance. L. para-
casei strain KW3110 was identified as a potent in-
ducer of IL-12 and repressor of IL-4 in a study of 101
strains that were tested in vitro using ovalbumin
(OVA)sensitized Th2-polarized mice splenocytes . 1
Some studies indicate that clinical symptoms and in-
flammation markers for allergy are alleviated after ad-
ministration of probiotic bacteria.2-5 The mechanisms
of efficacy of the probiotic bacteria may be mediated
by both immune stimulation and improvement of
composition of the intestinal flora. The proof of an in-
verse association between bacterial infections and al-
lergy has led to the “hygiene hypothesis” 6 that sug-
gests the recent rapid rise in allergy and autoimmune
diseases is a result of improved hygiene and reduced
bacterial infections.7 Therefore, a corollary of the hy-
giene hypothesis would be that allergic diseases im-
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Fig. 1　Comparison of immune stimulating activities between L. paracasei strain KW3110 and L. del-
bruecki strain B on OVA-sensitized BALB/c splenocytes. Secretion of IL-12 and IL-4 from OVA sensitized 
BALB / c splenocytes was determined by ELISA. A concentration of 1 μg / ml of each LAB strain was 
added to each culture and 7 days culture supernatants were analyzed. Each bar represents the mean ± 
SD of 6 mice. 
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Table 1 Characteristics of patients enroled in the study
P valueL. delbrueckiL. paracasei
－1414n
0.9539.039.0Age (y)
－5 : 98 : 6Sex (male : female)
0.349.815.6sIgE (UA/ml)
0.37123.4241.0tIgE (IU/ml)
0.46194.3154.3Epsinophils (counts /μl)
0.4615.613.5ECP (μg/L)
0.4114.012.0Th1/Th2
0.0726.820.1Th1 (%)
0.662.22.4Th2 (%)
prove by administration of some microbes. LAB are
non-pathogenic, gram-positive bacteria that should be
candidates for treatment of allergic diseases by oral
administration．
In Japan, one fourth of the population suffers from
allergy that is primarily caused by cedar pollen. The
allergy season in Japan occurs between the winter to
spring seasons during the natural dispersal of the ce-
dar pollen. We have conducted a double-blind clinical
trial to compare the effect of feeding yogurts manu-
factured by either L. paracasei strain KW3110 or Lac-
tobacillus delbrueckii strain B. Serum allergy mark-
ers8-10 in study participants were compared in the
groups ingesting the two different yogurts during the
major pollen allergy season in Japan.
METHODS
IN VITRO CYTOKINE SECRETION IN MICE
SPLENOCYTES
OVA-primed splenocytes were used for in vitro stud-
ies. Female 6 week old BALBc mice(Charles River,
Yokohama, Japan)were injected intraperitoneally with
1 mg of OVA absorbed onto 2 mg of Al(OH)3(Wako,
Tokyo, Japan). Injections were given twice on day 0
and on day 6 post initial immunization. On day 13
mice were sacrificed to obtain splenocytes. After lysis
of RBC, splenocytes were suspended at the concen-
tration of 2×106 cellsml in RPMI medium(Sigma,
MO, USA)supplemented with 10% FCS and penicil-
linstreptomycin. Cells were cultured for 7 days with
1 mgml OVA, in either the presence or absence of 1
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Fig. 2　Th1 / Th2 ratios in individual study participants before (Jan) and after (Apr) supplementa-
tion for 12 weeks with yogurt manufactured by either L. paracasei strain KW3110 or L. delbruecki 
strain B. P values are shown in brackets at the top of each panel. NS = not significant (P>0.05)
P=0.0052
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μgml of bacteria.
BACTERIAL STRAINS
L. paracasei strain KW3110 and L. delbrueckii strain B
were maintained at Koiwai Dairy Products Co., Ltd.
For the mouse cytokine secretion assay , bacteria
were grown at 37℃ for 48 hr in MRS broth(DIFCO,
MI, USA). Cultured bacteria were washed twice with
sterile distilled water , heat-killed at 100℃ , lyophil-
ized, and suspended in PBS．
SUBJECTS
Twenty-eight adult patients who suffered from cedar
pollen allergy participated in the study. All patients
were employed by Kirin Brewery Co., Ltd and Koiwai
Dairy Products Co., Ltd. Cedar pollen-specific IgE-
positive(>0.34 UAml)patients were selected as sub-
jects. Patients were allowed to use drugs only when
they displayed severe symptoms. There was one pa-
tient for each group who had used magistral drugs.
The study was conducted according to the ethical
standards of our company, which required informed
consent from each patient.
STUDY DESIGN
A double-blind design was used. Subjects were ran-
domly divided into 2 groups of 14 patients per group.
The 12-week study began in January 2003, before the
pollen season, and ended after pollen season, in April
2003. The yogurts produced by the 2 strains of bacte-
ria(L. delbrueckii strain B and L. paracasei strain KW
3110 )were fed individually to participants in each
group. The characteristics of patients of both groups
when this study had begun are shown in Table 1. No
significant difference was observed between L. para-
casei strain KW3110 group and L. delbrueckii strain B
group in all parameters. However, there was a trend
for the L. delbrueckii stain B group to be higher than
L. paracasei strain KW3110 group in Th1 cells(P=
0.07). Each subject was given 200 ml yogurt daily for
12 weeks. Both types of yogurt were manufactured
by Koiwai Dairy Foods, Co., Ltd and contained about
2×108cfuml.
QUANTITATION OF EOSINOPHILS AND SERUM
ECP
Heparinized blood samples were collected every 4
weeks and serum was stored at −80℃. ECP measure-
ments were performed from 4 ml blood samples. ECP
levels were measured with Uni-Cap ECP kit and an
automated fluoroenzyme assay analyzer ( Uni-Cap
100)following the manufacturer’s instructions(Phar-
macia Diagnostics, Uppsala, Sweden)．
SERUM IgE MEASUREMENT
Commercial kits(Pharmacia Diagnostics)were used
to measure both total serum IgE(Uni-Cap total IgE)
and cedar pollen specific IgE(Uni-Cap Japanese cedar
specific IgE)using the Uni-Cap 100 automated analy-
sis．
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Fig. 3　Percentages of Th1 cels in individual participants before (Jan) and after (Apr) supplemen-
tation for 12 weeks with yogurt manufactured by either L. paracasei strain KW3110 or L. del-
bruecki strain B. 
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TH1TH2 RATIO MEASUREMENT
500 μl of each blood sample were incubated at 37℃
for 4 hrs in 500 μl RPMI-1640(Sigma)supplemented
with 12.5 μg of phorbol 12-miristate 13-acetate
(Sigma), 1 μg of ionomysin(Sigma)and 5 μg of bre-
feldin A ( Sigma ) . Then cells were collected and
stained with APC-conjugated mouse anti human CD4
(Beckman Coulter, MI, USA). Cells were fixed for 15
min at room temperature in FACS lysing solution
(Becton Dickinson, CA, USA) . Cells were treated
with FACS permeabilizing solution 2(Becton Dickin-
son ) according to the manufacturer’s instructions .
Cells were stained for IFN-γ to quantify Th1 cells and
IL-4 to quantify Th2 cells with FASTIMMUNE IFN-γ
FITCIL-4 PE(Becton Dickinson)for 30 min on ice,
washed in dPBSBSA, and stored in the dark at 4℃．
Samples were analyzed on a Becton Dickinson FACS
caliber flow cytometer using the CellQuest software
package. Live gating on lymphocytes or CD4+ events
was performed during acquisition. The CD4+, IFN-γ+
population and the CD4+, IL-4+ population were de-
fined as Th 1 and Th 2 cells , respectively . The
Th1Th2 ratio was calculated by dividing the percent-
age of the Th1 population by the percentage of Th2
population.
STATISTICS
The serum parameter data were analyzed by Wilcox-
son’s signed rank test when comparing the data be-
fore and after the cedar pollen season and by the
Mann-Whitney U-test when compared the data of
both groups. The differences in treatment are given
as the mean with 95% confidence intervals. A P value
less than or equal to 0.05 was considered to indicate a
statistically significant difference．
RESULTS
IN VITRO EFFECTS OF TH1TH2 BALANCE IM-
PROVEMENT IN MICE
The ability of the LAB strains being studied to induce
the Th1 cytokine IL-12 and the Th2 cytokine IL-4 pro-
duction was compared in supernatants of Th2-skewed
splenocyte culture. The L. paracasei strain KW3110
was a potent inducer, while the L. delbrueckii strain B
was a poor inducer of IL-12 (Fig. 1). Repression of IL-
4 production was observed only with L . paracasei
strain KW3110. Otherwise , because these 2 LAB
strains had such different immunomodulating activi-
ties in the mouse model, they were appropriate for
subsequent comparative studies of immunomodulat-
ing activities in humans.
EFFECT OF LAB GIVEN IN YOGURT ON
TH1TH2 RATIOS
In the group given yogurt with L. delbrueckii strain B,
the Th1Th2 ratio was significantly decreased(P=
0.0052)after cedar pollen season as compared to the
values of samples taken before the season began
(Fig. 2). No significant changes were detected be-
tween the samples taken before the beginning and af-
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Fig. 4　Percentages of Th2 cels before (Jan) and after (Apr) supplementation for 12 weeks with 
yogurt manufactured by either L. paracasei strain KW3110 or L. delbruecki strain B.
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ter the end of cedar pollen season in the L. paracasei
strain KW3110 study group. To investigate whether
the Th1 or Th2 cell counts were responsible for the
differences between the two study groups, the popu-
lation cell counts were compared rather than the ra-
tios. Th1 cells were significantly decreased for both
groups during cedar pollen season (Fig. 3). However,
a trend toward increases in Th2 cells was observed in
participants given the L . delbrueckii strain B (P=
0.0555). However no significant changes in percent-
ages of either Th1 or Th2 cells were observed in the
L. paracasei strain KW3110 study group (Fig. 4).
EFFECT OF LAB GIVEN IN YOGURT ON SERUM
ECP
In the group given L. delbrueckii strain B yogurt, se-
rum ECP was significantly increased(P=0.0157)when
the before and after cedar pollen season values were
compared (Fig. 5). There were no significant changes
in the group given the L. paracasei strain KW3110.
Eosinophil count was significantly increased(P<0.01)
in both groups(data not shown).
DISCUSSION
We have previously shown that a wide variety of IL-
12-inducing and IL-4-repressing activities are depend-
ent upon the strain, not the species, of LAB.1 The mo-
lecular characteristics that distinguish potent from
weak immune stimulating bacteria are under investi-
gation. Very small differences, such as carbohydrate
antigen structure, may impact on the potential for im-
mune stimulation. To begin to analyze the basis of
strain differences, we chose to use the L. paracasei
strain KW3110 as a potent immune stimulator and
the L. delbrueckii strain B as a weak immune stimula-
tor. Using yogurt made by those LAB strains, the ef-
fects on human pollen allergy were investigated .
Most of the previous clinical studies used placebo
controls with no LAB, rather than comparing individ-
ual LAB strains, as immune modulators.2-5,11-13 Such
studies can estimate the optimum immune stimulat-
ing ability of LAB, but cannot account for the differ-
ences between various LAB strains . We were con-
cerned that the comparative studies of LAB strains in
humans would give unclear results . However the
strain differences were evident when we compared
results in participants fed yogurt made by the L. del-
brueckii strain B with the group given L. paracasei
strain KW3110 yogurt. The differences in Th2 cell
counts are probably the reason for the differences be-
tween the two groups in the Th1Th2 ratios. We have
already shown that oral administration of KW3110 in-
creased IL-12 secretion , decreased IL-4 secretion
from splenocytes, but had no effect on IFN-γ secre-
tion.1 In the present study, Th1 cell counts were sig-
nificantly decreased in both study groups during the
period of observation. Anti-allergic effects resulting
from oral administration of LAB might be attributable
to improvement of Th2 differentiation . The cedar
pollen-specific IgE levels were significantly increased
in both groups both before and after cedar pollen sea-
son . However , when the data from February and
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Fig. 5　ECP values in study participants before (Jan) and after (Apr) supplementation for 12 
weeks with yogurt manufactured by either L. paracasei strain KW3110 or L. delbruecki strain B.
P=0.0157NS
50
40
E
C
P
 (
µg
 / 
L)
E
C
P
 (
µg
 / 
L)
30
20
10
0
50
40
30
20
10
0
Jan Jan AprApr
L.paracasei KW3110 L.delbrueckii B
March were compared , there was a significant in-
crease for the L. delbrueckii strain B but not for the
L. paracasei strain KW3110 group(data not shown).
The amount of LAB ingested by test subjects was
much lower than quantities of bacterial flora normally
resident in the intestinal tract . Nonetheless , differ-
ences in immunological parameters were still ob-
served. There may be gut immunity related recogni-
tion mechanisms that differentiate between foreign
and inherent bacteria. The gut immune system may
become tolerant to the inherent bacteria . The in-
gested LAB may enter the gut mucosa through the M
cells that are located in Peyer’s patches. Dendritic
cells may also mediate bacterial uptake in the mu-
cosal tissues. 14 The understanding of how bacteria
enter the intestinal mucosa may help to explain the
differences in anti-allergic effects between LAB
strains．
Lactobacillus rhamnosus GG is one of the most ex-
tensively studied probiotic strains . Oral probiotic
therapy with L. rhamnosus GG has shown promise as
a therapeutic agent in small children with food al-
lergy.15 Also, L. rhamnosus GG is effective in prevent-
ing early atopic disease in children.5 However oral
treatment of L. rhamnosus GG had no effect on birch
pollen allergy . 16 Our previous studies have shown
that IL-12-inducing and IL-4-repressing activities of
L. rhamnosus GG are only 50% of the activities of the
L. paracasei strain KW3110.1 The use of a potent im-
mune stimulating strain of LAB for clinical trials of
anti-allergic effects may be necessary to give consis-
tent results．
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